ENTX
USDEntera Bio Ltd. Ordinary Shares
$2.800+0.070 (2.564%)
Real-time Price
Healthcare
Biotechnology
Israel
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.730
High
$2.920
Low
$2.450
Volume
0.12M
Company Fundamentals
Market Cap
127.9M
Industry
Biotechnology
Country
Israel
Trading Stats
Avg Volume
0.15M
Exchange
NCM
Currency
USD
52-Week Range
Low $1.501Current $2.800High $2.97
Related News
GlobeNewswire
Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women
Consistency of BMD gains presented at NAMS 2025 demonstrate EB613's efficacy in both young postmenopausal women and in women 10 years post-menopause Data further support EB613 potential as a first-in-class oral
View more
Related Stocks
ZBH
Zimmer Biomet
SP500
Health Care Equ...
NEO
NeoGenomics Inc.
NASDAQ
Precision Instr...
BIAFW
bioAffinity Technologies Inc. Warrant
NASDAQ
Biotechnology: ...
XOMAO
XOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock
NASDAQ
Biotechnology: ...
NAMSW
NewAmsterdam Pharma Company N.V. Warrant
NASDAQ
Biotechnology: ...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.